echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > For the first time in E. coli, CRISPR/Cas9 technology was used to achieve high-efficiency editing of four genes at the same time.

    For the first time in E. coli, CRISPR/Cas9 technology was used to achieve high-efficiency editing of four genes at the same time.

    • Last Update: 2020-08-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The genome editing technology of industrial microorganisms is the research foundation and hot spot of microbial metabolic engineering, and the establishment of CRISPR/Cas9 system has greatly promoted the development of genome editing technology.
    however, the problem of crispR/Cas9 multigene simultaneous editing efficiency still exists in the model bio-E. coli, and the lack of effective genome editing methods for Ralstonia eutropha, which has great potential for industrial application, severely restricts the in-depth study of Roche's real bacteria.
    recently, the research team of microbial metabolic engineering and synthetic biotechnology led by Zhang Xueli, a researcher of Tianjin Institute of Industrial Biotechnology of the Chinese Academy of Sciences, led by Bi Changxuan, used CRISPR/Cas9 technology for the first time in E. coli to achieve high-efficiency editing of four genes, with two genes, three genes and four genes editing efficiency at the same time reaching 100%, 90% and 40% respectively.
    results have been published in Biotechnology Journal, Tianjin Institute of Technology Assistant Researcher Zhao Dongdong and master's student Feng Xu as the first author of the paper. In addition, the team has developed an efficient genome editing method in Roche's true bacteria,
    .
    increased the efficiency of strain conversion by three orders of magnitude by knocking out the restrictive endoenzyme gene in Roche's gene-restriction modification system, and achieved gene editing efficiency of 78.3-100% using CRISPR-Cas9-mediated homologous recombination (HR).
    this technology overcomes the technical bottleneck of Roche's genome editing, provides a new method of genetic modification of the strain, and lays the foundation for the industrialization application of the bacteria.
    results have been published in the journal Biotechnology for Biofuels, with Xiong Bin, a doctoral student at Tianjin Institute of Technology, as the first author of the paper.
    research supported by the National "863" (2015AA02020202), the Key Projects of the Tianjin Science and Technology Support Program (14ZCZDSY00067) and the Key Deployment Project of the Chinese Academy of Sciences (ZDRW-ZS-2016-3).
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.